224 related articles for article (PubMed ID: 20012052)
21. Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol.
Álvarez Troncoso J; Soto Abánades C; Robles-Marhuenda Á; Alcolea Batres S; Fernández Velilla Peña M; Jiménez Valero S; Sorriguieta Torre R; Rios-Blanco JJ
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38191213
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
[TBL] [Abstract][Full Text] [Related]
25. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause.
Akdogan A; Kilic L; Dogan I; Okutucu S; Er E; Kaya B; Coplu L; Calguneri M; Tokgozoglu L; Ertenli I
J Clin Rheumatol; 2013 Dec; 19(8):421-5. PubMed ID: 24263143
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE.
Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH
Lupus; 2002; 11(4):227-33. PubMed ID: 12043886
[TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
30. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
Monti M; Borgognoni F; Pastacci L; Vincentelli GM
G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
[TBL] [Abstract][Full Text] [Related]
31. DIAGNOSTIC VALUE OF LABORATORY MARKERS OF SYNTROPIC LESIONS OF THE CIRCULATORY SYSTEM ORGANS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Kobak L; Abrahamovych O; Abrahamovych U; Maksymuk A; Ivanochko R
Georgian Med News; 2023; (340-341):159-164. PubMed ID: 37805891
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus.
Lian F; Chen D; Wang Y; Ye Y; Wang X; Zhan Z; Xu H; Liang L; Yang X
Rheumatol Int; 2012 Jun; 32(6):1727-31. PubMed ID: 21437686
[TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension].
Luo RQ; Lei YX; Zhang X; Liang F
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1860-3. PubMed ID: 18971190
[TBL] [Abstract][Full Text] [Related]
35. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
[TBL] [Abstract][Full Text] [Related]
36. Case report. Two cases of pulmonary hypertension with Raynaud's phenomenon. Primary pulmonary hypertension and systemic lupus erythematosus.
Kanemoto N; Gonda N; Katsu M; Fukuda J
Jpn Heart J; 1975 May; 16(3):354-60. PubMed ID: 1160186
[TBL] [Abstract][Full Text] [Related]
37. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
Taraborelli M; Cavazzana I; Martinazzi N; Lazzaroni MG; Fredi M; Andreoli L; Franceschini F; Tincani A
Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
[TBL] [Abstract][Full Text] [Related]
38. Screening for Pulmonary Hypertension in Antiphospholipid Antibody Positive Lupus Erythematosus.
Chogle AR
J Assoc Physicians India; 2015 Apr; 63(4):13-5. PubMed ID: 26591163
[No Abstract] [Full Text] [Related]
39. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
40. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
